<DOC>
	<DOCNO>NCT01154829</DOCNO>
	<brief_summary>The investigator want relate disturbance first-episode schizophrenic patient ( dopaminergic ) D2 receptor , brain structure , brain function , information processing psychopathology . Additionally , investigator want examine influence D2 receptor blockade disturbance . The investigator expect disturbance dopaminergic system baseline correlate specific structural functional change disruption information processing measure psychophysiological neurocognitive method - investigator expect D2 receptor blockade reverse functional cognitive impairment .</brief_summary>
	<brief_title>Pan European Collaboration Antipsychotic Naive Schizophrenia ( PECANS )</brief_title>
	<detailed_description>The study design 6 week case-control follow-up study 70 AN FE pt . SCZ 70 control match regard age , gender , parental socio-economic status . All subject examine diagnostic interview ( SCAN , Schedule Clinical Assessment Neuropsychiatry ) , medical family history , physical examination inclusion . At baseline subject examine single photon emission compute tomography ( SPECT ) , MRI , fMRI , psychophysiology , neurocognition . In addition , screen drug , genetic testing , ECG . Patients examine clinical validate rating scale measure psychopathology , subjective well-being , side-effects . After period 6 week assessments repeat . During period patient treat amisulpride , healthy control receive treatment . Efficacy antipsychotic treatment evaluate initial period 6 week . Based evaluation decide either continue current ( amisulpride ) antipsychotic treatment , switch aripiprazole . Efficacy aripiprazole evaluate monthly basis , patient respond well enough , treatment adapt individually . Regardless treatment , subject re-assessed test battery mention , except SPECT fMRI , period 6 , 12 , 24 month . The developement specific disturbance relationship analyse .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<criteria>For patient : meeting diagnostic criterion schizophrenia accord ICD 10 DSM IV antipsychotic naive The control match patient accord gender age parental socioeconomic status . Patients : mental retardation , chronic disease , use antidepressive medicine last month , pregnant , go substance abuse Controls : psychiatric diagnosis , psychiatric diagnosis firstdegree relative , go drug abuse , mental retardation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>dopamine</keyword>
	<keyword>first episode</keyword>
	<keyword>reward</keyword>
	<keyword>cognition</keyword>
	<keyword>MRI</keyword>
	<keyword>fMRI</keyword>
	<keyword>PPI</keyword>
	<keyword>P300</keyword>
	<keyword>P50 gating</keyword>
	<keyword>endophenotypes</keyword>
</DOC>